Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joyce Murphy

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Beginnings (American Holistic Nurses' Association)|September 13, 2011
AHNA as a holistic workplaceJoyce Murphy
Internal Medicine Journal|December 8, 2016
Moving beyond 'not enough time': factors influencing paediatric clinicians' participation in researchSimon P Paget, Patrina H Y Caldwell, Joyce Murphy, et al.
Microbiology Spectrum|November 24, 2021
Broad-Spectrum <i>In Vitro</i> Antiviral Activity of ODBG-P-RVn: An Orally-Available, Lipid-Modified Monophosphate Prodrug of Remdesivir Parent Nucleoside (GS-441524)Michael K Lo, Punya Shrivastava-Ranjan, Payel Chatterjee, et al.
Biorxiv : the Preprint Server for Biology|September 2, 2020
Rethinking Remdesivir: Synthesis, Antiviral Activity and Pharmacokinetics of Oral Lipid ProdrugsRobert T Schooley, Aaron F Carlin, James R Beadle, et al.
Antimicrobial Agents and Chemotherapy|July 26, 2021
Rethinking Remdesivir: Synthesis, Antiviral Activity, and Pharmacokinetics of Oral Lipid ProdrugsRobert T Schooley, Aaron F Carlin, James R Beadle, et al.
Antiviral Research|September 27, 2023
Enhanced broad spectrum in vitro antiviral efficacy of 3-F-4-MeO-Bn, 3-CN, and 4-CN derivatives of lipid remdesivir nucleoside monophosphate prodrugsRachel E McMillan, Michael K Lo, Xing-Quan Zhang, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Beginnings (American Holistic Nurses' Association)|September 13, 2011
AHNA as a holistic workplaceJoyce Murphy
Internal Medicine Journal|December 8, 2016
Moving beyond 'not enough time': factors influencing paediatric clinicians' participation in researchSimon P Paget, Patrina H Y Caldwell, Joyce Murphy, et al.
Microbiology Spectrum|November 24, 2021
Broad-Spectrum <i>In Vitro</i> Antiviral Activity of ODBG-P-RVn: An Orally-Available, Lipid-Modified Monophosphate Prodrug of Remdesivir Parent Nucleoside (GS-441524)Michael K Lo, Punya Shrivastava-Ranjan, Payel Chatterjee, et al.
Biorxiv : the Preprint Server for Biology|September 2, 2020
Rethinking Remdesivir: Synthesis, Antiviral Activity and Pharmacokinetics of Oral Lipid ProdrugsRobert T Schooley, Aaron F Carlin, James R Beadle, et al.
Antimicrobial Agents and Chemotherapy|July 26, 2021
Rethinking Remdesivir: Synthesis, Antiviral Activity, and Pharmacokinetics of Oral Lipid ProdrugsRobert T Schooley, Aaron F Carlin, James R Beadle, et al.
Antiviral Research|September 27, 2023
Enhanced broad spectrum in vitro antiviral efficacy of 3-F-4-MeO-Bn, 3-CN, and 4-CN derivatives of lipid remdesivir nucleoside monophosphate prodrugsRachel E McMillan, Michael K Lo, Xing-Quan Zhang, et al.
Pageof 1